Skip to main content
Signal8
Giles Lisa M. profile photo

Lisa M. Giles

CIK: 0001568850

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Milestone Pharmaceuticals Inc. logo
MIST

Milestone Pharmaceuticals Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Milestone Pharmaceuticals Inc. logo
    MIST

    Milestone Pharmaceuticals Inc.

    Jun 10, 2026
    Award(A)

    Stock Option (right to buy)

    Direct
    77K shares-
  • Milestone Pharmaceuticals Inc. logo
    MIST

    Milestone Pharmaceuticals Inc.

    Jun 10, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    40K shares-

1-2 of 2

About Giles Lisa M.

Giles Lisa M. (SEC CIK 0001568850) files insider reports with the SEC as Director of Milestone Pharmaceuticals Inc. (MIST).

Signal8 holds 2 ownership filings by Giles Lisa M., all Form 4s, filed between Jun 12, 2025 and Jun 12, 2026. Those filings report 2 transactions, from Jun 10, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Giles Lisa M.'s filings is in MONTREAL.

Recent filings by Giles Lisa M.

  • Jun 10, 2026: Grant or award of MIST derivative securities (Form 4, code A).
  • Jun 10, 2025: Grant or award of MIST derivative securities (Form 4, code A).

Other insiders filing for Milestone Pharmaceuticals Inc. (MIST)

How to read Form 4 transaction codes